Glioblastoma, the most common type of glioma, is associated with very poor survival, so glioma epidemiology has focused on identifying factors that can be modified to prevent this disease.

Dr. Chen is developing a new delivery system which is designed to help cancer drugs cross the blood-brain barrier.